Product Details

Sofracort

Framycetin Sulfate + Gramicidin + Dexamethasone
5 mg + 50 mcg + 0.5 mg/mL
Ophthalmic/Otic Solution


DIN/PIN/NPN

02224623

Manufacturer

Sanofi Aventis Pharma

Formulary Listing Date

2001-10-11  

Unit Price

2.1263

Amount MOH Pays

2.1263

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Sofracort: The risk of ototoxicity with topical aminoglycoside may increase with prolonged therapy. Topical use of antibiotics increases the likelihood of development of bacterial resistance, especially with prolonged use, sometimes rendering the systemic use of this antibiotic class useless in these patients.

ATC Code

S03CA01

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph